March 24, 2017 6:15 AM ET

Healthcare Equipment and Supplies

Company Overview of CHEK Diagnostics

Company Overview

CHEK Diagnostics designs, manufactures, and markets point-of-care diagnostics products to customers in the United States and internationally. It offers A1CNow+ and A1CNow SELF CHECK that provides glucose control average results in the office or home; PTS Detect cotinine system for tobacco-use detection with a handheld device; and PTS Pod blood collection systems. The company also provides CardioChek PA, CardioChek Plus, and CardioChek Home Cholesterol Test System analyzers that are used for cholesterol management by medical professionals; PTS Panels test strips to perform total cholesterol, HDL cholesterol, triglycerides, and glucose tests by medical professionals; PTS Panels controls that o...

7736 Zionsville Road

Indianapolis, IN 46268

United States

Founded in 1992





Key Executives for CHEK Diagnostics

Chief Executive Officer, President and Director
Age: 57
Chief Financial Officer
Director of Operations
Vice President of Technology & Development
Compensation as of Fiscal Year 2016.

CHEK Diagnostics Key Developments

PTS Diagnostics Launches PTS Detect Cotinine System

PTS Diagnostics announced that the company has launched a new product line of handheld medical devices that provide rapid point-of-care test results previously only available from a venous draw sent to a laboratory. PTS Detect™ systems will allow healthcare professionals to further expand the number of fingerstick tests with results provided at the point of care. The first product in this new family innovates tobacco-use detection. The PTS Detect cotinine system is the only point-of-care device offering quantitative results from a fingerstick. The PTS Detect cotinine system is a portable device offering specific, reliable, accurate and fast results. The PTS Detect system measures quantified cotinine (a byproduct of nicotine) levels from 25 ng/ml to 200 ng/ml in just 5 minutes. In recent evaluations, the portable PTS Detect system provided results with similar sensitivity and specificity ranges as laboratory instruments. Another benefit is the cost savings that can be realized with the PTS Detect cotinine system. As a fingerstick test, the expense of employing phlebotomists is eliminated. With no shipping of specimens to the laboratory and fewer confirmatory tests, the PTS Detect cotinine system is well-positioned for the workplace. Further, the fingerstick collection can be done in conjunction with other onsite screenings.

Similar Private Companies By Industry

Company Name Region
.decimal, Inc. United States
20/20 GeneSystems, Inc. United States
20/20 Imaging LLC United States
21st Century Scientific, Inc. United States
21X Corporation United States

Recent Private Companies Transactions

May 2, 2016

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
Bertelsmann AG Europe
Bloomberg L.P. United States
The Advertising Council, Inc. United States
Rush University United States

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact CHEK Diagnostics, please visit Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at